| Patient | Ernest Shackleton |
|---|---|
| Date of birth | 1979-02-15 |
| Identifiers | MRN HR-EX001-SYN; SSN (made up) 000-01-7763 |
| Document date | 2026-11-01 |
| Author | Cormac Ellingsworth-Daly, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for chest tightness and breathlessness on exertion in a heavy smoker planning a polar expedition: risk assessment, ECG and blood tests, starting treatment, smoking and alcohol counseling, and a cardiology referral. Concerns: He is afraid a heart diagnosis will stop the expedition he has promised to lead; He will be weeks from a hospital at sea and in the far south. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 | active | S |
| Atorvastatin 80 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 | active | S |
| Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 to 2026-05-26 | stopped | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 doses | as needed for chest pain, up to 3 doses | Sublingual route | 2026-05-12 | active | S |
| Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration | twice a day after titration | Oral route | 2026-05-12 | active | S |
| Metoprolol succinate extended-release 100 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-26 | active | S |
| Clopidogrel 75 mg tablet, one tablet by mouth daily for six months after the stent (600 mg loading dose before the procedure) | once daily for six months | Oral route | 2026-07-01 | active | S |
| Ezetimibe 10 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-07-21 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Resting twelve-lead electrocardiogram | 2026-05-12 to 2026-05-12 | completed | S |
| Coronary CT angiography with coronary calcium score and CT-derived fractional flow reserve | 2026-05-26 to 2026-05-26 | completed | S |
| Transthoracic echocardiogram with color Doppler and agitated-saline study | 2026-05-26 to 2026-05-26 | completed | S |
| Invasive coronary angiography with a drug-eluting stent in the proximal left anterior descending artery, by the radial artery | 2026-07-01 to 2026-07-01 | completed | S |
| Symptom-limited exercise treadmill test (Bruce protocol) | 2026-09-08 to 2026-09-08 | completed | S |
| Advance care planning conversation, about 20 minutes | 2026-08-11 to 2026-08-11 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-08-11 | Tdap vaccine | completed | S |
| 2026-08-11 | Pneumococcal conjugate vaccine (PCV20) | completed | S |
| 2026-09-08 | Influenza vaccine, 2026-2027 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1903 | Breathlessness and weakness that stopped him pulling a sledge on a polar journey in his late twenties, attributed at the time to scurvy and asthma; sent home | D (CLM-0002) |
| January 20, 1908 | Very unwell after heavy hauling on a rope on a polar expedition in his thirties; a pulmonary systolic murmur heard twice by the expedition doctor | D (CLM-0003) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He is afraid a heart diagnosis will stop the expedition he has promised to lead | active | S |
| He will be weeks from a hospital at sea and in the far south | active | S |
Most recent measures: Cholesterol [Mass/volume] in Serum or Plasma 108 on 2026-09-08; Cholesterol in HDL [Mass/volume] in Serum or Plasma 45 on 2026-09-08; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 44 on 2026-09-08; Triglyceride [Mass/volume] in Serum or Plasma 95 on 2026-09-08; Hemoglobin A1c/Hemoglobin.total in Blood 5.7 on 2026-09-08; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-06-23; Creatinine [Mass/volume] in Serum or Plasma 0.96 on 2026-06-23; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 2026-07-21; Hemoglobin [Mass/volume] in Blood 15.6 on 2026-06-23; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 2026-05-12; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 98 on 2026-06-23; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-08-11; Total score [AUDIT] 12 on 2026-05-12; Left ventricular Ejection fraction 58 on 2026-05-26; Platelets [#/volume] in Blood by Automated count 245 on 2026-06-23; Total score [AUDIT-C] 3 on 2026-09-08 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requested | resolved | confirmed | R07.89 | S — Synthetic presenting problem anchored to his documented exertional breathlessness; superseded by the diagnosis at the cardiology consultation. |
| Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years) | active | confirmed | F17.210 | S — Synthetic modern coding anchored to his documented heavy smoking. |
| Chronic coronary disease with stable exertional angina: 80% stenosis of the proximal left anterior descending artery with CT-FFR 0.70, mild right coronary artery disease, coronary calcium score 210, and normal left ventricular function; synthetic modern episode linked to his documented exertional illnesses and the coronary atheroma recorded at his death | active | confirmed | I25.118 | S — Synthetic modern diagnosis made at the cardiology consultation; Macklin's coronary diagnosis is recorded in CLM-0009 and the alternative theories as R. |
| Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intake | active | confirmed | E78.5 | S — Synthetic modern risk factor; no historical measurement exists. |
| Prediabetes: HbA1c 5.9% at intake | active | confirmed | R73.03 | S — Synthetic modern risk factor; no historical measurement exists. |
| Drug-eluting stent in the proximal left anterior descending artery, placed for angina that persisted on medical therapy; dual antiplatelet therapy for six months | active | confirmed | Z95.5 | S — Synthetic status after the modern procedure. |
| Acute low back strain after lifting crates of stores, without sciatica or red flags; managed without NSAIDs because he takes aspirin and clopidogrel; resolved | resolved | confirmed | S39.012A | S — Synthetic acute problem; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-12 | Cholesterol [Mass/volume] in Serum or Plasma | 246 | mg/dL | <=199 mg/dL | High | S |
| 2026-05-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 38 | mg/dL | >=40 mg/dL | Low | S |
| 2026-05-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 168 | mg/dL | Below 100 for the general population; below 55 is his treatment target | High | S |
| 2026-05-12 | Triglyceride [Mass/volume] in Serum or Plasma | 200 | mg/dL | <=149 mg/dL | High | S |
| 2026-05-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | % | <=5.6% | High | S |
| 2026-05-12 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-05-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 7-52 U/L | Normal | S |
| 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 15.8 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-05-12 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-05-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 96 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-05-12 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-05-12 | Total score [AUDIT] | 12 | {score} | S | ||
| 2026-05-26 | Left ventricular Ejection fraction | 58 | % | 52-72% | Normal | S |
| 2026-06-23 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-06-23 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-06-23 | Hemoglobin [Mass/volume] in Blood | 15.6 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-06-23 | Platelets [#/volume] in Blood by Automated count | 245 | 10*3/uL | 140-400 10*3/uL | Normal | S |
| 2026-06-23 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 98 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-07-21 | Cholesterol [Mass/volume] in Serum or Plasma | 128 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-07-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-07-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 62 | mg/dL | Below 100 for the general population; below 55 is his treatment target | Normal | S |
| 2026-07-21 | Triglyceride [Mass/volume] in Serum or Plasma | 110 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-07-21 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 7-52 U/L | Normal | S |
| 2026-07-21 | Total score [AUDIT-C] | 4 | {score} | S | ||
| 2026-09-08 | Cholesterol [Mass/volume] in Serum or Plasma | 108 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-09-08 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 45 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-09-08 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 44 | mg/dL | Below 100 for the general population; below 55 is his treatment target | Normal | S |
| 2026-09-08 | Triglyceride [Mass/volume] in Serum or Plasma | 95 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-09-08 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.7 | % | <=5.6% | High | S |
| 2026-09-08 | Total score [AUDIT-C] | 3 | {score} | S | ||
| 2026-08-11 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-12 | Body height | 175 | cm | S |
| 2026-05-12 | Body weight | 86 | kg | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 28.1 | kg/m2 | S |
| 2026-05-12 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-05-12 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-05-12 | Heart rate | 78 | /min | S |
| 2026-05-12 | Respiratory rate | 16 | /min | S |
| 2026-05-12 | Body temperature | 36.7 | Cel | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-05-26 | Body height | 175 | cm | S |
| 2026-05-26 | Body weight | 85.6 | kg | S |
| 2026-05-26 | Body mass index (BMI) [Ratio] | 28 | kg/m2 | S |
| 2026-05-26 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-05-26 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-05-26 | Heart rate | 66 | /min | S |
| 2026-05-26 | Respiratory rate | 14 | /min | S |
| 2026-05-26 | Body temperature | 36.6 | Cel | S |
| 2026-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-06-23 | Body height | 175 | cm | S |
| 2026-06-23 | Body weight | 85 | kg | S |
| 2026-06-23 | Body mass index (BMI) [Ratio] | 27.8 | kg/m2 | S |
| 2026-06-23 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-06-23 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-06-23 | Heart rate | 60 | /min | S |
| 2026-06-23 | Respiratory rate | 14 | /min | S |
| 2026-06-23 | Body temperature | 36.6 | Cel | S |
| 2026-06-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-07-21 | Body height | 175 | cm | S |
| 2026-07-21 | Body weight | 84.4 | kg | S |
| 2026-07-21 | Body mass index (BMI) [Ratio] | 27.6 | kg/m2 | S |
| 2026-07-21 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-07-21 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-07-21 | Heart rate | 58 | /min | S |
| 2026-07-21 | Respiratory rate | 14 | /min | S |
| 2026-07-21 | Body temperature | 36.7 | Cel | S |
| 2026-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-09-08 | Body height | 175 | cm | S |
| 2026-09-08 | Body weight | 83 | kg | S |
| 2026-09-08 | Body mass index (BMI) [Ratio] | 27.1 | kg/m2 | S |
| 2026-09-08 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-09-08 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-08 | Heart rate | 58 | /min | S |
| 2026-09-08 | Respiratory rate | 14 | /min | S |
| 2026-09-08 | Body temperature | 36.6 | Cel | S |
| 2026-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-08-11 | Body height | 175 | cm | S |
| 2026-08-11 | Body weight | 83.8 | kg | S |
| 2026-08-11 | Body mass index (BMI) [Ratio] | 27.4 | kg/m2 | S |
| 2026-08-11 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-08-11 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-08-11 | Heart rate | 60 | /min | S |
| 2026-08-11 | Respiratory rate | 14 | /min | S |
| 2026-08-11 | Body temperature | 36.6 | Cel | S |
| 2026-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-08-25 | Body height | 175 | cm | S |
| 2026-08-25 | Body weight | 83.5 | kg | S |
| 2026-08-25 | Body mass index (BMI) [Ratio] | 27.3 | kg/m2 | S |
| 2026-08-25 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-08-25 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-08-25 | Heart rate | 70 | /min | S |
| 2026-08-25 | Respiratory rate | 16 | /min | S |
| 2026-08-25 | Body temperature | 36.7 | Cel | S |
| 2026-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-05-12 | New patient visit for chest tightness and breathlessness on exertion in a heavy smoker planning a polar expedition: risk assessment, ECG and blood tests, starting treatment, smoking and alcohol counseling, and a cardiology referral | finished | S |
| 2026-05-26 | Two-week follow-up and cardiology consultation with coronary CT angiography and echocardiogram | finished | S |
| 2026-06-23 | Six-week review: angina on medical therapy, smoking, and a shared decision about coronary angiography and stenting | finished | S |
| 2026-07-21 | Ten-week review: three weeks after the stent, lipids, cardiac rehabilitation, smoking and alcohol | finished | S |
| 2026-09-08 | Four-month review before departure: exercise test, lipids, HbA1c, and the expedition medical plan | finished | S |
| 2026-08-11 | Periodic adult preventive visit | finished | S |
| 2026-08-25 | Same-day sick visit for low back pain | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Cardiology consultation in two weeks with coronary CT angiography for suspected stable angina, and advice on revascularization and on fitness for the expedition | completed | GL-AHA-CCD-2023, GL-ESC-CCS-2024 | S |
| Medical therapy from intake for suspected angina: aspirin 81 mg, atorvastatin 80 mg, metoprolol succinate, and sublingual nitroglycerin with written instructions to call emergency services if pain lasts more than 5 minutes after the first dose | completed | GL-AHA-CCD-2023, GL-ESC-CCS-2024, GL-CMID-2026 | S |
| Stop smoking: varenicline for 12 weeks, with the option of 12 more, a quit date in one week, counseling at each visit, and the quitline | completed | GL-USPSTF-TOB-2021, GL-AHA-CCD-2023 | S |
| AUDIT with a brief intervention for hazardous drinking: no more than two drinks a day and several alcohol-free days a week, with AUDIT-C at follow-up | completed | GL-USPSTF-ALC-2018, GL-AHA-CCD-2023 | S |
| Prediabetes: diet and activity counseling and HbA1c in about four months | completed | GL-USPSTF-DM-2021, GL-AHA-CCD-2023 | S |
| Raise metoprolol succinate to 100 mg for persisting angina, with an echocardiogram, and revascularization of the proximal LAD lesion if angina persists despite medical therapy or he prefers it after a shared decision | completed | GL-AHA-CCD-2023, GL-ESC-CCS-2024 | S |
| Expedition plan: a symptom-limited exercise test before departure, a written cardiac summary with ECG and stent card, three months' extra medicines split between two bags, an automated external defibrillator and emergency cardiac medicines on board, a satellite link for telemedicine, an evacuation plan to the nearest cardiac centers along the route, and advice on cold stress | completed | GL-AHA-CCD-2023, GL-ESC-CCS-2024 | S |
| Invasive coronary angiography with a drug-eluting stent to the proximal LAD, then aspirin with clopidogrel for six months and aspirin alone after | completed | GL-AHA-CCD-2023, GL-ESC-CCS-2024 | S |
| Cardiac rehabilitation after the stent, three sessions a week until departure, with a home exercise plan for the voyage | completed | GL-AHA-CCD-2023, GL-CMID-2026 | S |
| Add ezetimibe 10 mg because LDL cholesterol was 62 mg/dL on atorvastatin 80 mg, above the target below 55 | completed | GL-ESC-CCS-2024, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| No cigarettes from the quit date, confirmed at each visit | 2026-09-08 | completed | Not smoked since the quit date a week after intake; varenicline continued to 24 weeks | S |
| LDL cholesterol below 55 mg/dL with at least a 50% reduction by four months | 2026-09-08 | completed | 44 mg/dL, from 168 | S |
| Blood pressure below 130/80 mmHg by six weeks | 2026-06-23 | completed | 128/80 at six weeks | S |
| Free of angina in daily activity, and a symptom-limited exercise test of at least 10 METs without ischemia before departure | 2026-09-08 | completed | No angina since the stent; about 12.8 METs without angina or ST changes | S |
| Drinking within the low-risk limit, with an AUDIT-C below 4, by four months | 2026-09-08 | completed | AUDIT-C 3, from an AUDIT of 12; two drinks at most on four evenings a week | S |
| At least 15 sessions of cardiac rehabilitation before departure | 2026-09-08 | completed | 18 sessions completed | S |